Seed Media Group

Terra Sigillata

musings on medicines from the Earth

Search this blog

Profile

Abel%20sharpened%20reduced%20150px.jpg Abel Pharmboy is the nom de plume of an academic researcher and educator who holds a PhD in Pharmacology. He writes on natural product drugs and dietary supplements, academic career development, medical journalism and, occasionally, making and listening to music and, with the help of his colleague, Erleichda, wine appreciation.

Terra Sigillata is the name of the first authenticated, trademarked drug. "Why Terra Sigillata?" will tell you more about the origin of the blog name.

You can learn quickly the distinction between the fields of Pharmacology, Pharmacognosy, Pharmacy, the Pharmaceutical Sciences by clicking on the hyperlinks.

Learn more about the author and the origin of "Abel Pharmboy" here.

Please feel free to contact me off-blog by e-mail to abelpharmboy (at) gmail (dot) com.

Please read the DISCLAIMER for details on the blog's intended audience, advertising and comment policy, and how not to use the information presented herein.

DonorsChoose 2008


We comply with the HONcode standard for trustworthy health
information:
verify here.

 Subscribe in a reader

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Subscribe in Bloglines

http://www.wikio.com


OpenLab2006.png Openlab 2007

Recent Posts

Recent Comments

Subscribe via Email

Stay abreast of your favorite bloggers' latest and greatest via e-mail, via a daily digest.

Sign me up!

Archives

Blogroll

« More fallout from New Mexico garbage truck E. coli-gate - up from the comments | Main | ScienceOnline'09: a special message to the pseudonymous blogger »

Bush administration adopts NIH plan to shorten applications

Category: HumorPoliticsThe Working Scientist
Posted on: September 22, 2008 8:16 PM, by Abel Pharmboy

I had to laugh, through my tears of course, that the Bush administration's bill requesting $700 billion for the Treasury Department to purchase failing mortgage assets is not even three pages long.

Where did the idea come from for such a concise funding request???

Those of us with NIH research funding received e-mails last week on the outcome of "Enhancing Peer Review," a year-long effort by the funding agency to "fund the best science, by the best scientists, with the least amount of administrative burden."

One of the outcomes garnering the greatest attention has been the proposal to reduce the application page-limit of the R01 from 25 pages to 12 pages. This code, R01, is the NIH's term for the bread-and-butter, investigator-initiated research grant that is the basis for any academic biomedical research career and the primary metric for promotion and tenure. The R01 generally provides $250,000 of support per year for up to five years; while this sounds like a great deal of money, one must pay part of one's salary plus two to four individuals in the lab, plus a fringe benefit rate of 20-35% as prescribed by one's institution, plus any materials and operational costs (yes, research associates and postdocs: the university tells you that they pay your retirement and benefits but it is actually your boss who earned the grant from NIH).

Many words have been spilled elsewhere to note that the shortened proposal length will disproportionately place junior investigators at an disadvantage since senior investigators can replace pages with reference citations that they have been doing technique X since the Magna Carta.

But hey, even 12 pages for $250,000 per year is a good deal. Even if one considers a total project period of $1.25 million, that's just over $104,000 per page (yes, I'm not getting into the other 50 or more pages of supplemental information required.)

In contrast, the Wall Street rescue bill is even more direct: $233 billion per page (and that's an underestimate since it is less than three pages.) Assuming that one page is 250 words, that's $933 million perword.

Hence, I believe that NIH overestimated the page limit for their $1.25 million grant applications.

A simple comma would be more than enough.

Comments

"will disproportionately place junior investigators at an advantage"

Is that supposed to be disadvantage?

Posted by: MRW | September 22, 2008 11:45 PM

Thanks, MRW - fixed!

Posted by: Abel Pharmboy | September 23, 2008 12:49 PM

Post a Comment

(Email is required for authentication purposes only. Comments are moderated for spam, your comment may not appear immediately. Thanks for waiting.)





Having problems commenting? (UPDATED)

Blogs in the Network

Advertisement

Top Five: Most German

Search All Blogs